EPISODE · May 10, 2025 · 13 MIN
Global Postoperative Pain Therapeutics Market Report 2025 - Its Size, Trends and Forecast
from Market Research Webinars · host Cognitive Market Research
The postoperative pain therapeutics market is transforming the global pain management landscape. With the growing emphasis on patient recovery, safety, and opioid alternatives, this episode explores the evolving treatment landscape—from non-opioid medications and local anesthetics to innovative multimodal approaches like ERAS protocols. We also spotlight Hikma Pharmaceuticals' February 2024 launch of COMBOGESIC IV in the U.S.—a new opioid-free IV painkiller combining 1,000 mg acetaminophen and 300 mg ibuprofen. Tune in to understand the shift towards safer, more effective postoperative pain relief.
What this episode covers
The postoperative pain therapeutics market is transforming the global pain management landscape. With the growing emphasis on patient recovery, safety, and opioid alternatives, this episode explores the evolving treatment landscape—from non-opioid medications and local anesthetics to innovative multimodal approaches like ERAS protocols. We also spotlight Hikma Pharmaceuticals' February 2024 launch of COMBOGESIC IV in the U.S.—a new opioid-free IV painkiller combining 1,000 mg acetaminophen and 300 mg ibuprofen. Tune in to understand the shift towards safer, more effective postoperative pain relief.
NOW PLAYING
Global Postoperative Pain Therapeutics Market Report 2025 - Its Size, Trends and Forecast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.